ECM
HOLX

Endurant Capital Management’s Hologic HOLX Stock Holding History

Endurant Capital Management’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,631
Closed -$831K – 12
2023
Q4 		$831K Sell
11,631
-6,119
-34% -$426K 4.76% 9
2023
Q3 		$1.23M Buy
+17,750
New +$1.34M 1.11% 28
2022
Q3 		– Sell
-127,656
Closed -$8.85M – 58
2022
Q2 		$8.85M Buy
127,656
+4,032
+3% +$299K 3.1% 11
2022
Q1 		$9.5M Sell
123,624
-57,444
-32% -$4.13M 2.5% 14
2021
Q4 		$13.9M Sell
181,068
-19,051
-10% -$1.4M 3.35% 9
2021
Q3 		$14.8M Buy
200,119
+89,279
+81% +$6.7M 3.36% 7
2021
Q2 		$7.39M Buy
+110,840
New +$7.41M 2.03% 18
2020
Q3 		– Sell
-81,789
Closed -$4.66M – 63
2020
Q2 		$4.66M Sell
81,789
-391,878
-83% -$19.2M 0.26% 24
2020
Q1 		$16.6M Buy
+473,667
New +$22.6M 7.53% 3
2019
Q1 		– Sell
-135,805
Closed -$5.58M – 77
2018
Q4 		$5.58M Buy
135,805
+42,760
+46% +$1.75M 2.95% 14
2018
Q3 		$3.81M Buy
93,045
+9,389
+11% +$380K 1.7% 25
2018
Q2 		$3.33M Sell
83,656
-87,288
-51% -$3.36M 1.44% 21
2018
Q1 		$6.39M Sell
170,944
-51,900
-23% -$2.1M 2.39% 17
2017
Q4 		$9.53M Buy
222,844
+119,641
+116% +$4.77M 2.91% 8
2017
Q3 		$3.79M Buy
103,203
+84,774
+460% +$3.42M 1.15% 30
2017
Q2 		$836K Sell
18,429
-101,129
-85% -$4.46M 0.24% 73
2017
Q1 		$5.09M Sell
119,558
-80,400
-40% -$3.28M 1.64% 25
2016
Q4 		$8.02M Sell
199,958
-22,600
-10% -$872K 3.31% 6
2016
Q3 		$8.64M Buy
222,558
+54,350
+32% +$2.05M 3.2% 8
2016
Q2 		$5.82M Buy
168,208
+106,508
+173% +$3.69M 1.95% 18
2016
Q1 		$2.13M Sell
61,700
-3,800
-6% -$133K 0.69% 41
2015
Q4 		$2.53M Buy
65,500
+57,100
+680% +$2.22M 0.85% 39
2015
Q3 		$329K Buy
+8,400
New +$333K 0.11% 72
2015
Q2 		– Sell
-174,540
Closed -$5.76M – 100
2015
Q1 		$5.76M Sell
174,540
-54,000
-24% -$1.66M 1.9% 17
2014
Q4 		$6.11M Buy
+228,540
New +$5.9M 2.4% 13

Other funds holding HOLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Endurant Capital Management's HOLX Position: Q1 2024 in Review

Endurant Capital Management sold out of Hologic (HOLX) in Q1 2024, closing a stake of 11,631 shares — an estimated $831K sold.

Endurant Capital Management first reported a position in HOLX in Q4 2014 and held it in 25 quarters. The position peaked at $16.6M in Q1 2020. 706 funds tracked by Wall St. Rank hold HOLX as of Q1 2024.

  • Endurant Capital Management reported no remaining Hologic position as of Q1 2024 after selling out during the quarter.
  • Endurant Capital Management sold 11,631 Hologic shares in Q1 2024, an estimated $831K.
  • Endurant Capital Management first reported a position in Hologic in Q4 2014 and held it in 25 quarters.
  • Endurant Capital Management's Hologic position peaked at $16.6M in Q1 2020.
  • 706 funds tracked by Wall St. Rank held Hologic as of Q1 2024.

Based on Endurant Capital Management's 13F filing for Q1 2024.